Like CD27‐, CD70‐deficient patients, RASGRP1‐deficient patients appear to be particularly prone to develop EBV‐driven B‐cell lymphoma as the four patients described today had Hodgkin lymphoma. Here, RASGRP1 is linked to B-cell non-Hodgkin lymphoma.